Popularity #3,774Earnings in 5d
CHRN · NASDAQ · Information Technology Services

ChronoScale (CHRN)

Dedicated GPU compute infrastructure and wearable robotic devices.

$20.75
vs last close−0.45 (−2.12%)
Loading prices…

ChronoScale CorporationCHRN
Information Technology

Sells dedicated GPU compute environments for AI and high-performance workloads, earning managed-services revenue through customer contracts. Also owns Ekso Bionics, which sells wearable robotic devices and related services, creating a business mix spanning cloud infrastructure and regulated medical devices.

Provides dedicated, single-tenant GPU compute environments for AI training, inference and high-performance-computing workloads. The ChronoScale Platform is configured around customer deployment requirements and combines customer-specific architecture, deployment and ongoing operations; equipment runs in third-party colocation centers in Colorado, Minnesota and Utah.

Also owns Ekso Bionics, which sells and supports wearable robotic devices for rehabilitation, personal mobility and industrial use. Its lines include FDA-cleared EksoNR, Ekso Indego Therapy and Ekso Indego Personal, alongside Ekso EVO and service offerings such as extended warranties, training, repairs and device-data access.

Earns managed-cloud-services revenue at fixed rates over contracts that are typically month-to-month or annual. Cloud customer concentration, leased colocation facilities and third-party equipment and service providers remain central operating dependencies; the medical-device business depends on regulatory clearances and payer processes.

Company facts

CEOYing Cenly Chen
ListedMay 5, 2026
ExchangeNASDAQ
HeadquartersDallas, TX
CountryUnited States
Employees61
CIK0001549084
ISINUS1709241046

Market cap$75.5M
EPS (ttm)
P/E (ttm)
ROE
P/B
P/S
Dividend yieldDiv yield
Beta

No analyst consensus on record.

Next report
Sep 28, 26
in 5 days
EPS estimate
−$0.03
Revenue estimate
$18.1M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Oct '24Mar '25May '25Jul '25Oct '25Sep '26
Reported−$1.50−$2.10−$1.80−$1.24−$0.54Pending
Estimate−$1.58−$1.20−$1.65−$1.35−$0.97−$0.03
Surprise+4.8%−75.0%−9.1%+8.1%+44.0%

RevenueReportedEstimate

Oct '24Mar '25May '25Jul '25Oct '25Sep '26
Reported$4.1M$5.1M$3.4M$2.1M$4.2MPending
Estimate$5.6M$5.1M$4.6M$4.3M$4.2M$18.1M
Surprise−25.6%+0.8%−27.0%−52.3%+1.7%
Estimate−$0.03
ReportedDue Sep 28, 2026
Estimate$18.1M
ReportedDue Sep 28, 2026
View details

Not reported.

No dividends on record.

Insiders10.24%364.8K shares
1 holder · as of Aug 18, 2026
Other89.76%3.20M shares
remainder

3.56M company shares as of Aug 22, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Jerome WongInsiderofficer: Chief Financial Officer
10.24%364,771filed Aug 18, 2026

Insider tradesForm 4

No open-market trades in the last 12 months.

View details

  • CoreWeave

    Dedicated GPU cloud for AI training, inference and HPC.

  • Amazon

    Hyperscale AI compute and managed model services.

  • Microsoft

    Enterprise AI infrastructure and GPU cloud capacity.

  • Oracle

    AI training infrastructure with hyperscale and dedicated options.

  • Alphabet Class A

    AI cloud infrastructure using TPUs, GPUs and Vertex AI.

  • Lifeward

    Lower-limb exoskeletons for rehabilitation and personal mobility.

Compare

CompanyPriceChange
ChronoScale$20.75−2.12%$75.5M+2.4%
CoreWeave$87.74+1.13%$47.33B6.2+112.3%
Amazon$249.82−2.02%$2.74T20.526.83.5+19.6%
Microsoft$501.08+0.62%$3.70T27.725.611.1+17.8%
Oracle$145.46−2.45%$429.54B23.417.16.0+29.6%
Alphabet Class A$339.37−3.36%$4.25T17.625.39.5+24.2%
Lifeward$6.95+0.14%$11.2M0.5+15.7%
Median21.925.46.1+21.9%